Kaiku Health Oy, a Helsinki, Finland-based digital health company, raised €4.4m in funding.
The round was led by Debiopharm Innovation Fund SA and Tesi with participation from Prodeko Ventures Oy and existing investors Reaktor Ventures Oy, Metsola Ventures Oy, and Athensmed Oy.
The company will use the funds for its international expansion and further develop its digital therapeutics pipeline.
Led by Lauri Sippola, CEO and Co-Founder, Kaiku Health provides intelligent patient monitoring software for healthcare providers across Europe.
The company offers intelligent patient monitoring software for healthcare providers, mainly in oncology. Structured capture and analysis of patient-reported data enables clinicians to evaluate the effectiveness of therapies and to detect and treat health problems early. Kaiku Health platform is used in routine care by over 30 clinics in Switzerland, Germany, Italy, Sweden, and Finland, and has been used by 64,000 patients (March 2018).